ScreenerHero
CORCencora, Inc.
NYSE · US · Healthcare · Medical Distribution · cencora.com
298.55USD+0.69%Mkt Cap: 58.09B $P/E: 22.88

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter…

Industry Peers

Medical Distribution
Screen all
vs Medical Distribution
P/E
Avg
P/B
Pricier
Div Yield
Avg
1M Perf
Lower
MCK
McKesson Corporation
$91.82BUSDP/E 20.4
CAH
Cardinal Health, Inc.
$55.63BUSDP/E 36.3
HSIC
Henry Schein, Inc.
$9.87BUSDP/E 26.2
GALE
Galenica AG
$4.93BUSDP/E 23.7
ASKER
Asker Healthcare Group AB (publ)
$3.05BUSDP/E 53.3
AMP
Amplifon S.p.A.
$3.07BUSDP/E 34.3
SELEC
Selçuk Ecza Deposu Ticaret ve Sanayi A.S.
$3.08BUSDP/E 111.7
UPR
Uniphar plc
$1.36BUSDP/E 25.4
NEU
NEUCA S.A.
$805.69MUSDP/E 18.4
ARJO-B
Arjo AB (publ)
$695.09MUSDP/E 20.7
M12
M1 Kliniken AG
$380.06MUSDP/E 15.6
ILM1
Medios AG
$333.79MUSDP/E 21.5
BLC
Bastide Le Confort Médical SA
$190.27MUSDP/E 19.0
MLFMV
Farminveste, S.G.P.S., S.A.
$131.69MUSD
NAVA
Navamedic ASA
$37.55MUSD
RMAH
Farmaceutica REMEDIA S.A.
$17.16MUSDP/E 10.5
ALEMG
Laboratoires Euromedis Société anonyme
$15.15MUSD
Indicators:|

Key Statistics

Company
Market Cap58.09B $
Enterprise Value68.16B $
Revenue (TTM)328.68B $
Gross Profit11.48B $
Net Income (TTM)1.55B $
Revenue/Share1693.17 USD
Last Price298.55 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees47.0K
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)22.88
P/E (Forward)14.30
PEG0.61
EV/EBITDA12.86
EV/Revenue0.21
P/S0.17
P/B16.20
EPS (TTM)13.05
EPS (Forward)19.79
52W Range
244.8240% of range377.54
52W High377.54 USD
52W Low244.82 USD
Profitability
Gross Margin3.57%
Oper. Margin1.72%
EBITDA Margin1.61%
Profit Margin0.48%
ROE103.06%
ROA2.03%
Growth
Revenue Growth3.80%
Earnings Growth128.30%
Cash Flow & Leverage
Operating CF3.88B $
CapEx (TTM)667.98M $
FCF Margin-0.10%
FCF Yield-0.55%
Net Debt12.92B $
Net Debt/EBITDA2.44
Balance Sheet
Debt/Equity5.08
Current Ratio0.95
Quick Ratio0.48
Book Value/Sh17.46 USD
Cash/Share11.19 USD
Dividends
Fwd Div Rate2.400 USD
Trail. Div Rate2.300 USD
Div. Yield0.85%
5Y Avg Yield1.01%
Payout Ratio17.62%
Ex-Div DateMay 15, 2026
Pay DateJun 1, 2026
Splits
Last Split2:1
Split DateJun 16, 2009
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)351.00 USD
Upside (mean)+17.6%
Target Range285.00 USD – 412.00 USD
$285.00+17.6% to mean$412.00
# Analysts12
Ownership
Shares Out.194.56M
Float184.01M
Insiders4.23%
Institutions98.85%
Short Interest
Short Ratio3.9d
Short % Float3.64%
Short % Out.3.21%
Shares Short6.24M
Short (prev mo.)5.29M
Technical
SMA 50281.17 (+6.2%)
SMA 200324.43 (-8.0%)
Beta0.59
S&P 52W Chg20.05%
Avg Vol (30d)1.09M
Avg Vol (10d)1.82M
Technical Indicators
RSI (14)66.9
MACD3.8623
MACD Signal1.5399
MACD Hist.+2.3224
BB Upper296.18 USD
BB Middle282.15 USD
BB Lower268.11 USD
BB Width9.95%
ATR (14)7.482 USD
Vol Ratio (20d)1.48x